CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Scientific Officer bought 5,000 shares at $1.41 ($7,050)
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 100,000 shares at $1.38 ($138,000)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $1.36 ($6,800)
- 4 Open-market buy Director bought 5,000 shares at $1.24 ($6,200)
- 4 Open-market buy Director bought 100,000 shares at $1.30 ($130,000)
- 4 Open-market buy Director bought 5,000 shares at $1.29 ($6,450)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4/A Derivatives Options or other derivatives
- 4 Other disposition Shareholder disposed of 10,496,760 shares (other)
- SC 13G Stake Amended Statement of Ownership
- 8-K/A Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement
Page 23 of 29 · 576 filings